Ghasemi A, Pourali R, Zadeh J. K, Akbari M. Studying the Correlation Between Serum Level of 25- hydroxyvitamin D and Glucose Metabolism During Pregnancy. Biomed Pharmacol J 2016;9(3).

---

Manuscript received on :December 01, 2016
Manuscript accepted on :December 19, 2016
Published online on: --

---

How to Citeclose    |   Publication History close

 Views: 

Visited 418 times, 1 visit(s) today

 

 PDF Downloads: 

1643

Afasaneh Ghasemi¹, Roghaye Pourali^2*, Jalil Kouhpayeh Zadeh³ and Maryam Akbari²

¹Department of Gynecology and Midwifery, Shahid Akbar Abadi Hospital, Iran University of Medical Sciences, Tehran, Iran.

²Shahid Akbar Abadi Hospital, Iran University of Medical Sciences, Tehran, Iran.

³Department of Social Medicine, Medical School , Iran University of Medical Sciences, Tehran, Iran.

Corresponding Author Email: Roghayehpourali@ymail.com

DOI : https://dx.doi.org/10.13005/bpj/1044

Abstract

There are conflicting ideas concerning the correlation between serum levels of 25-hydroxivatmin D and side effects of pregnancy. The present research seeks to study the correlation between lack of this vitamin and glucose metabolism in pregnancy. In this Cross-sectional research, as many as 330 women aging 18 to 35 in the 24^th to 28^th week of their pregnancy and fully aware of the process entered this project after their consent was gained. They underwent public screening for diabetes through 50-gram oral glucose challenge test (GCT). The serum level of HbA1C and 25-hydroxyvitamin D and analysis of urine for glucose were measured at the same time when the level of blood sugar was assessed. As for those people whose blood sugar 1 hour after receiving 50 g oral glucose was equal to or more than 140 mg/dl, the two-hour OGTT diagnosis test was carried out with 75 grams of glucose. The average levels of Vitamin D and HbA1C were compared with one another among the participants. Variables such as mother’s age, parity, family history of diabetes, and BMI of mother were recorded in the checklists. Data was analyzed by SPSS20 software using T-test, Correlation, and K2 statistical methods. The average age of the mothers participating in this research and their average level of parity were 26.78 ± 4.5 and 1.89 ± 0.92 respectively. There were 48 cases (14.5%) with pregnancy diabetes, while 282 cases (85.5%) had no sign of diabetes. The serum level of vitamin D was above 30 ng/dl in 9 subjects (2.7%), while this level was below 20 ng/dl in 321 people (93.7%). A reverse significant correlation was observed between the serum level of vitamin D and average levels of HbA1C (p=0.006 and r=0.15). a significant difference was observed in Glucosuria between the diabetic and non-diabetic people (p=0.001) but it had no significant correlation between the level of vitamin D. Prevalence of vitamin D deficiency in this research is really high. The routine assessment of this vitamin before pregnancy and the necessity of correcting its deficiency and prescription of vitamin d supplements and its effect on OGTT results,needs more researches more researches.

Keywords

25-hydroxivitamin D; gestational diabetes; Glucose Metabolism

Introduction

Lack of vitamin D is a common phenomenon among people suffering from type 2 diabetes and pregnant women. It may act as a dangerous factor for metabolic syndrome in these people and replacing vitamin D would reduce resistance to insulin (1). In patients suffering from gestational diabetes and especially those with type 2 diabetes, the concentration of D during pregnancy will remain less than what is observed in healthy women. As shortage of vitamin D, diabetes and gestational diabetes are common in Iran, studying the correlation of these diseases with one another can help identify its pathogenesis particularly because no clear link has been established yet between shortage of vitamin D and sugar tolerance and insulin resistance during pregnancy. As one of the main characters of gestational diabetes is resistance to insulin and people are exposed to type 2 diabetes, studying the patients suffering from diabetes can provide us with a good sample for the comprehensive study of diabetes. Taking these issues into consideration, the present research seeks to study the correlation between the serum level of 25-hydroxivitamin D and glucose mechanism during pregnancy. Vitamin D or calciferol and her metabolites are soluble in fat and its metabolism (1- and 25-di hydroxyvitamin D) depend upon the hemostasis of calcium and the serum level of calcium and phosphor is regulated through Parathyroid hormone. Estrogen, placental growth hormone and prolactin influence the metabolism of vitamin D and result in greater demand for calcium during pregnancy.

There are a few foods that contain vitamin D such as egg and fat fish. The main source of this vitamin is the synthesis inside the skin. Vitamin D₃ (Cholecalciferol) is synthesized when sunlight (UV) reaches 7-di hydrocholesterol inside our skin. It is hydroxylated in liver and then in kidneys and finally turns into the active form of 1- and 25-di hydroxy vitamin D. The extra-skeletal effects of vitamin D are great, it influences our immune and cardiovascular systems, and her shortage results in paresis and higher risks of affliction with cancer. It has also been studied in metabolic syndrome and diabetes. It is involved in type 1 Mellitus diabetes as it influences the immune system. As for type 2 diabetes, it helps increase the activity of  cells and help cure insulin sensitivity. Obesity is usually accompanied with lower concentrations of 25OHD. The risk of affliction with type 2 diabetes among those women who receive sufficient levels of vitamin D was reported to be much less in several researches (2,3).

Various researches have shown these complications in 25OHD serum level to be less than 20 ng/ml (50 nmol/l). Prescription of vitamin D supplements is regulated based on the patient (4). As for those with high risks of fracture or falling and 25OHD levels below 20 ng/ml of vitamin D, 50000 oral units are prescribed weekly for 6 to 8 weeks. As for pregnant women, the weekly dose of 50000 for 6 to 8 weeks is not reliable and a daily dose of 600 to 800 units is prescribed (5).

Lack of vitamin D results in various side effects including pregnancy complications: gestational diabetes, preeclampsia, infections and limited growth of the fetus. Various studies have failed to come up with a clear definition for lack of vitamin D during pregnancy, but they have shown that lack of vitamin D within the first trimester results in higher pregnancy complications (6). Although the favorable supplementary dose of vitamin D is not clear, prescription of vitamin D supplements seems to be a simple yet useful intervention. Shortage of vitamin D is quite common among pregnant women and it may disrupt glucose metabolism. The extra-skeletal effects of vitamin D is an interesting topic for analysis and research. It is even involved in causing metabolic syndrome and type 2 mellitus diabetes. It is not clear how it influences glucose metabolism but it has a reverse correlation with glycosylated hemoglobin in pregnancy diabetes. Seemingly, it helps prevent pregnancy diabetes (7).

Shortage of vitamin D is a common complication among people with type 2 diabetes and pregnant women and it may constitute a dangerous factor of metabolic syndrome in these people (8) and replacing vitamin D reduces insulin resistance (9). As for those mothers suffering from pregnancy diabetes and particularly those with type 2 diabetes, the concentration of D will remain below the level reported in healthy mothers (10,11). As shortage of vitamin D, diabetes and gestational diabetes are common phenomena in Iran, studying the correlation of these diseases with one another can help identify a good pathogen for them particularly because no clear link has been established yet between shortage of vitamin D and sugar tolerance and insulin resistance during pregnancy. The majority of the researches have been conducted on animals in laboratories. As one of the main characters of gestational diabetes is resistance to insulin and people are exposed to type 2 diabetes, studying the patients suffering from diabetes can provide us with a good sample for the comprehensive study of diabetes. Taking these issues into consideration, the present research seeks to study the correlation between the serum level of 25-hydroxivitamin D and glucose mechanism during pregnancy.

Materials and Method

In the present cross-sectional research, pregnant women within their 24 and 28 week who had resorted to midwifery center of Firouzgar and Shahid Akbar Abadi Hospitals (February 2014 to March 2015) and were qualified for the research entered this project. Without any extra costs, urine examination to determine Glucosuria, HbA1C and serum level of 25-hydroxyvitamin  D were requested besides GCT. In the case of disrupted GCT (blood glucose equal to or more than 140 mg/dl after receiving 50 gr oral glucose), GTT was conducted with 75 grams of oral glucose. As for those people diagnosed with GDM (fasting blood sugar level 95 or 1 hour blood glucose 180 or 2 hour blood glucose 155) compared to normal people, glucosuria, HbA1C, and serum level of hydroxyvitamin D are compared. To reduce statistical error,  those patients taking vitamin D supplements were excluded from research. There were other variables measured in this research: age and BMI, number of deliveries, number of abortions and healthy deliveries, family history of affliction with diabetes among first grade relatives and background diseases such as diabetes, high blood pressure, hyperlipidemia, renal failure. The following inclusion criteria were defined: aging older than 18 and younger than 35 years old and being in the 24 to 28 week of pregnancy according to trimester sonography or LMP. These were the exclusion criteria: diseases influencing the serum levels of 25-hydroxyvitamin D like thyroid, parathyroid, renal and liver diseases, taking supplements with vitamin D, smoking cigarettes, overt diabetes or fasting blood sugar 126 or HbA1C  6.5 and obesity (BMI  30).

An author-made checklist corresponding to variables of research was used to register the data. LIAISON kit was used to measure vitamin D and Biosystem kits were utilized to measure blood sugar and HbA1C. Cochran formula was used to calculate the size of the sample. The final sample size was finally set to 330. SPSS v.20 was used to analyze the data and the central statistical indicators such as mean, standard deviation, and frequency percentage were calculated. Then, t-test, k2, and correlation tests were used to study the correlation between variables. A p-value below 0.05 was defined to be statistically significant. All the participants were fully aware of the research and entered it with full consent. None of the information was reported individually.

Results

The present research was conducted to find the correlation between the serum level of 25-hydroxyvitamin D and glucose metabolism in diabetes. As many as 330 pregnant women were studied in this research. First, CGT was carried out for everyone. 76 people (23%) had disrupted GCT and 254 (77%) had normal GCT. GTT was conducted on those 76 people and it turned out that 48 of them (63.2%) were suffering from GDM while 28 were diagnosed to be negative (36.8%). Of 330 women studied in this research, 48 (14.5%) were suffering from GDM and 282 (85.5%) were normal. The average age of the participants was 26.78±4.50 (18 to 35 years old). The average number of gravities in these people was 1.89 ± 0.92 (ranging 1 to 5). The average number of parity in these people was 0.61 ± 0.75 (ranging 0 to 3). The average number of abortions in these people was 0.28 ± 0.52 (ranging 0 to 3 times). 138 cases (41.8%) were in their first gravidity and 154 cases (46.6%) had at least one experience of child delivery and 13 of them had a past history of pregnancy diabetes. Table 1 represents the quantitative values in terms of diabetic and non-diabetic groups.

Table 1: Average quantitative quantities for participants

Levels of vitamin D were divided into 3 groups: deficiency (less than 20 ng/dl), insufficiency (20-30 ng/dl) and sufficiency (more than 30 ng/dl). 278 cases were reported with deficiency (84.2%), 43 were diagnosed with insufficient levels of vitamin D (13.03%) and 9 cases (2.72%) had sufficient levels of vitamin D.

Family history of affliction with overt diabetes among the close relatives of patients was questioned. Access to such information was denied in 59 patients. In the remaining 271 cases, positive histories were reported in 14.6% of diabetic and 8.5% of non-diabetic cases. The information is presented in table 2.

Table 2: Frequency of qualitative quantities among participants

The correlation between the levels of HbA1c among the participants and levels of vitamin D are presented in table 3.

Table 3: Average levels of HbA1c among the participants in terms of Vitamin D

As for the correlation between the average level of HbA1c and average levels of vitamin D among participants, a value of 0.006 was calculated for P and r = -0.15. No significant correlation was observed between average levels of vitamin D and gestational diabetes and glucosuria in this research.

Discussion

Vitamin D and its metabolites play a major role in calcium Homeostasis and bone metabolism. Various researches have pointed to the major role if the active form of this vitamin (1- and 25- Di-hydroxy-cholecalciferol) in regulating biological processes by activating gene expression through intercellular receptors  – like cellular development, differentiation and metabolism (1-10).

The role of vitamin D in non-skeletal structures has been studied in various researches. This vitamin seems to be useful in cardiovascular, digestive, and muscular systems. The exclusive receptor of this vitamin has been found on Pancreatic beta cells and it seems to have some influence over the glucose metabolism. This correlation, however, is not completely clear (12).

No definition concerning the favorable levels of vitamin D has been proposed so far and its serum level differs based upon race, place of residence, nutrition status, and socio-economic status of people. This vitamin passes through the Placenta and is involved in bone metabolism of fetus and causes unfavorable obstetrical complications such as early delivery, premature rupture of membrane, abortion, limited growth of fetus, preeclampsia, and gestational diabetes.

Various studies have studied the correlation between deficiency of vitamin D and glucose metabolism during pregnancy. Indicators such as frequency of affliction with gestational diabetes, serum level of HbA1C and insulin challenge tests (Quicki test) were used and the results were conflicting in some cases.

The review study conducted by Fariba Agha Jafari et al (2013) confirms higher risks of pregnancy diabetes and preeclampsia an low delivery weight as a result of vitamin D shortage. Parlea et al have also highlighted the fact that hypo-vitamin D during pregnancy is associated with higher risks of affliction with GDM (13,14). The average levels of vitamin D among the nondiabetic and diabetic people were 16.39 and 15.61 respectively. This difference was not significant (P-value = 0.133).

It should be noted that no significant correlation has been described between hypo-vitamin D and affliction with GDM by Yap and Farrant (15,16). As for the correlation between mother’s level of vitamin D and sensitivity to insulin and serum levels of HbA1C, some researches have been conducted by Magbouli et al. and Ahmed Ellithy. These studies have pointed to the reverse correlation between levels of this vitamin and levels of HbA1C and insulin sensitivity. They have claimed that this sensitivity may be due to the role vitamin D plays in production and secretion of insulin (17,18). The average level of HbA1C in the diabetic and nondiabetic groups in our research was 4.93 and 4.72 rendering the difference statistically significant (P = 0.001).

A reverse significant correlation was also observed between average level of HbA1C and levels of vitamin D (R = -0.15, P = 0.006). Some researches have defined multi-parity as a risk factor which causes shortage of vitamin D serum level (19). In this research, no significant correlation was found between the number of pregnancy among the diabetic and nondiabetic mothers and vitamin D level (P = 0.141).

Glucosuria is one of the symptoms which makes conducting Oral Glucose Tolerance Test mandatory in the first visit (20) and it can help the early diagnosis of gestational or overt diabetes. Glucosuria was observed among 20.8% and 5% of the diabetic and non-diabetic patients respectively which made this difference significant (P = 0.001). However, it had no significant difference with average levels of vitamin D in both groups.

Various researches have pointed to obesity as the risk factor that increases the possibility of affliction with pregnancy diabetes and shortage of vitamin D (21,22). No significant difference was observed among the diabetic and non-diabetic people in terms of BMI. The difference between the average BMI of the participants and serum level of vitamin D was not significant.

Conclusion

The deficiency of vitamin D was quite common and frequent in this research. This study never sought to study prescription of supplements and their effects on OGTT. Those cases taking supplements were excluded from the research. Sampling was conducted over a period of one year and exposure to sunlight might have affected the level of vitamin. As the social and economic status can directly influence nutrition, it may also have a direct effect on the serum level of vitamin D. No correlation was observed between the level of vitamin D and affliction with gestational diabetes although it had a reverse significant correlation with HbA1C. Further research can help confirm this correlation and determine the necessity of routine assessment of this vitamin and correcting its shortage before pregnancy.

References

1. Rodda CP,et al. Maternal Vitamin D Supplementation During Pregnancy Prevents Vitamin D Deficiency in the Newborn: An Open Label Randomised Controlled Trial .Clin Endocrinol (Oxf). 2015 Mar 2.
2. Burris HH, Camargo CA Jr.Vitamin D and gestational diabetes mellitus. Curr Diab Rep. 2014 Jan;14(1):451.
3. Xiao JP, et al. Low maternal vitamin D status during the second trimester of pregnancy: a cross-sectional study in Wuxi, China.PLoS One. 2015 Feb 6;10(2):e0117748.
4. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57: 258-61.
5. Park S,et al. Maternal vitamin D deficiency in early pregnancy is not associated with gestational diabetes mellitus development or pregnancy outcomes in Korean pregnant women in a prospective study.J Nutr Sci Vitaminol (Tokyo). 2014;60(4):269-7.
6. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologi. 1995; 38: 1239–45.
7. Mimouni F, Tsang RC, Hertzberg VS, Neumann V, Ellis K. Parathyroid hormone and calcitriol changes in normal and insulin dependent diabetic pregnancies. Obstet Gynecol 1989; 74: 49–53.
8. Sablok A,et al. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome.Clin Endocrinol (Oxf). 2015 Feb 14.
9. Olmos-Ortiz A, Avila E, Durand-Carbajal M, Díaz L. Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes.Nutrients. 2015 Jan 9;7(1):443-80.
10. Skowrońska-Jóźwiak E,et al. Effects of maternal vitamin D status on pregnancy outcomes, health of pregnant women and their offspring.Neuro Endocrinol Lett. 2014;35(5):367-72.
11. Harvey NC,et al. Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess. 2014 Jul;18(45):1-190.
12. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267(3 Pt 1):E356–E360.
13. Aghajafari F, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies.BMJ. 2013 Mar 26;346:f1169.
14. Parlea L, et al. Association between serum 25-hydroxyvitamin D in early pregnancy and risk of gestational diabetes mellitus. Diabet Med. 2012 Jul;29(7):e25-32.
15. Yap C, et al.Vitamin D Supplementation and the Effects on Glucose Metabolism During Pregnancy: A Randomized Controlled Trial. Diabetes Care. 2014 Apr 23.
16. Farrant HJ, Krishnaveni GV, Hill JC, Boucher BJ, Fisher DJ, Noonan K, Osmond C, Veena SR, Fall CH. Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr. 2009;63(5):646–652.
17. El Lithy A,et al.The relationship between low maternal serum vitamin D levels and glycemic control in  gestational diabetes assessed by HbA1c levels: an observational cross-sectional study.BMC Pregnancy Childbirth. 2014 Oct 13;14:362.
18. Maghbooli Z, Hossein-Nezhad A, Karimi F, Shafaei AR, Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev. 2008;24(1):27–32.
19. Andersen LB,et al. Parity and tanned white skin as novel predictors of vitamin D status in early pregnancy: a population-based cohort study. Clin Endocrinol (Oxf).2013 Sep;79(3):333-41.
20. FG Cunningham,kJ leveno,SL Bloom,CY Spong,JS Dashe,BL Hoffman,BM Casey,JS Sheffield,editors.williams obstetrics.24^th edition.New York:McGraw-Hill;2014.p:1125- 1143.
21. Martin KE, Grivell RM, Yelland LN, Dodd JM.The influence of maternal BMI and gestational diabetes on pregnancy outcome.Diabetes Res Clin Pract. 2015 Feb 23.
22. Harel Z, Flanagan P, Forcier M, Harel D. Low vitamin D status among obese adolescents: prevalence and response to treatment. J Adolesc Health.2011 May;48(5):448-52.